Evidence map›Paper›PMID 33879104›Full record

ArticleBMC cancer2021

Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.

Junzo Yamaguchi, Hiroki Moriuchi, Takashi Ueda, Yujo Kawashita, Takanori Hazeyama, Masaki Tateishi, Shigehisa Aoki, Kazuyoshi Uchihashi, Mikio Nakamura

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Junzo YamaguchiDepartment of Surgery, Fukuoka Seisyukai Hospital, Fukuoka, 811-2316, Japan. yamaguchi.jun5@gmail.com.ORCID http://orcid.org/0000-0003-4434-4342
Hiroki MoriuchiDepartment of Surgery, National Hospital Organization, Saga Hospital, Saga, Japan.
Takashi UedaDepartment of Surgery, Fukuoka Seisyukai Hospital, Fukuoka, 811-2316, Japan.
Yujo KawashitaDepartment of Surgery, Fukuoka Seisyukai Hospital, Fukuoka, 811-2316, Japan.
Takanori HazeyamaDepartment of Surgery, Fukuoka Seisyukai Hospital, Fukuoka, 811-2316, Japan.
Masaki TateishiDepartment of Surgery, Fukuoka Seisyukai Hospital, Fukuoka, 811-2316, Japan.
Shigehisa AokiDepartment of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan.
Kazuyoshi UchihashiDepartment of Pathology, National Hospital Organization, Saga Hospital, Saga, Japan.
Mikio NakamuraDepartment of Urology (Chair of the Board of Directors), Seisyukai Social Medical Corporation, Fukuoka, Japan.
National Sagamihara Hospital · JPFukuoka Tokushukai Hospital · JPKishokai Medical Corporation · JPSaga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInteractions between adipocyte and breast cancer (BC) cells have yet to be fully elucidated. Here we investigated the prognostic impact of marginal adipose tissue invasion in both luminal breast cancer (HR+/HER2-) and triple-negative breast cancer (TNBC) (HR-/HER2-).

methodsA total of 735 patients with early-stage invasive BC (1999-2014) were retrospectively registered. Median length of patient follow-up was 8.9 years. Survival curves were calculated using a Kaplan-Meier cumulative survival plot. The prognostic difference between two groups were assessed by the univariate Cox-proportional hazard regression model.

resultsPatients with adipose tissue invasion (n = 614) had a significantly poorer prognosis than those without adipose tissue invasion (n = 121) in overall survival (OS) (hazard ratio, 2.1; 95% Confidence interval [CI], 1.1 to 4.0; P = 0.025). While a poorer prognosis was observed in TNBC (n = 137) than in luminal BC patients (n = 496) (hazard ratio, 0.45; 95% CI, 0.30 to 0.68, P < 0.001), this aggressive nature of TNBC was noted in node-positive disease (hazard ratio, 0.3; 95% CI, 0.18 to 0.5, P < 0.001) but not in node-negative disease (hazard ratio, 0.78; 95% CI, 0.39 to 1.55, P = 0.472), and also noted in adipose tissue invasion-positive patients (hazard ratio, 0.4; 95% CI, 0.26 to 0.6, P < 0.001) but not in adipose tissue invasion-negative patients (hazard ratio, 0.73; 95% CI, 0.16 to 3.24, P = 0.675). In addition, although patients suffering from TNBC with adipose tissue invasion had a poorer outcome than those without adipose tissue invasion (hazard ratio, 3.63; 95% CI, 1.11 to 11.84; P = 0.033), the difference was not observed in luminal BC (hazard ratio, 1.75; 95% CI, 0.64 to 4.82; P = 0.277).

conclusionsAdipose tissue invasion was correlated with poor survival in TNBC. Cancer cell invasion into local fat may be a first step on cancer progression and systemic disease in TNBC.

Indexed as

Adipose TissueAdultAgedAged, 80 and overBiomarkers, TumorCell CommunicationFemaleHumansImmunohistochemistryKaplan-Meier EstimateMiddle AgedNeoplasm InvasivenessNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesBiomarkers, TumorAdipose tissue invasionLuminal breast cancerPatient survivalTriple-negative breast cancerTumor microenvironment

Identifiers

PMID33879104
PMCPMC8056529
OpenAlexW3118950398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.